Insider · CIK 0001827177
Elissa J. Schwartz
Files at GALT (GALECTIN THERAPEUTICS INC). First filing -, latest -.
Elissa J. Schwartz files SEC Form 4 as director at GALT (GALECTIN THERAPEUTICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Elissa J. Schwartz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 21, 2026 |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 27, 2025 |
Questions about Elissa J. Schwartz
Answered from the filings on this page, as of the latest one.
Is Elissa J. Schwartz buying or selling?
Elissa J. Schwartz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Elissa J. Schwartz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elissa J. Schwartz has 0.
Where does Elissa J. Schwartz file Form 4?
Elissa J. Schwartz has filed Form 4 at GALT (GALECTIN THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.